Dierks Jeffrey's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Jan 21, 2025
- Accession no.
- 0001415889-25-001825
- Filed
- Jan 21, 2025
- Trade date
- Jan 16-21, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.15M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dierks JeffreyCIK 0001821102 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Common Stock | MOption exerciseAcquired | +29,475 | $33.44 | +$985,644 | 29,475 | Direct | |
| Jan 16, 2025 | Common Stock | SSaleDisposed | −29,475 | $37.41 | −$1,102,659.75 | 0 | Direct | |
| Jan 21, 2025 | Common Stock | MOption exerciseAcquired | +1,123 | $33.44 | +$37,553.12 | 1,123 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −1,123 | $40.00 | −$44,920 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 | Common Stock | MOption exerciseDisposed | −29,475 | $0.00 | $0 | 6,738 | Direct | |
| Jan 21, 2025 | Common Stock | MOption exerciseDisposed | −1,123 | $0.00 | $0 | 5,615 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.